TIMP1 and retinitis pigmentosa: The exogenous application of TIMP-1 has been reported to significantly modulate the mosaics and restore their homogeneity in the retina of the rat model of retinitis pigmentosa and may be a potential therapeutic agent (Ji et al., 2014).